World’s only scaled non-Chinese pyridine producer, Rs 3,400 crore CDMO pipeline, Agro-CDMO facility live in record 14 months, semiconductor chemicals next  Spending Rs 2,000 crore over three years to transform a chemicals business from a product-led intermediates manufacturer into a customer-centric specialty chemicals and CDMO platform is a significantContinue Reading

  40% EBITDA margins, 25% ROCE, 14 commercialised molecules with blockbuster end-markets, and fermentation-based peptide capabilities that few peers globally can match The Indian contract research and development manufacturing organisation space has attracted enormous investor attention over the last several years — and for good reason. India’s combination of scientificContinue Reading

FPI access to deliverable bullion and metals contracts proposed, index derivatives on commodities coming, margin requirements easing  Commodity derivatives markets in India have a structural problem that has suppressed volumes relative to equity derivatives for years — a narrow participant base, limited product breadth and high margin requirements that raiseContinue Reading

HCV product upgrades delivering market share gains, LCV expanding addressable market, EV penetration in SCVs at 10% and rising  Commercial vehicle markets are rarely exciting. They follow freight cycles, infrastructure spending and fuel economics — and they reward patient, disciplined investors rather than momentum traders. Tata Motors’ commercial vehicle businessContinue Reading

EBITDA margin beat estimates by 70 basis points, new 4W EV program won, aerospace facility live in Lille, solar tracker expansion underway  Auto components companies rarely get credit for the diversification happening beneath the surface of their quarterly P&L. Belrise Industries is a case in point. The Q1FY27 headline numbersContinue Reading